BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu L, O'Kelly D, Schuetze R, Carlson G, Zhou H, Trawick ML, Pinney KG, Mason RP. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors. Molecules 2021;26:2551. [PMID: 33925707 DOI: 10.3390/molecules26092551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wadsworth BJ, Lee CM, Bennewith KL. Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts. Br J Cancer 2022. [PMID: 35031765 DOI: 10.1038/s41416-021-01691-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Guo Y, Wang H, Gerberich JL, Odutola SO, Charlton-Sevcik AK, Li M, Tanpure RP, Tidmore JK, Trawick ML, Pinney KG, Mason RP, Liu L. Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment. Cancers (Basel) 2021;13:4769. [PMID: 34638255 DOI: 10.3390/cancers13194769] [Reference Citation Analysis]
3 Drzyzga A, Cichoń T, Czapla J, Jarosz-Biej M, Pilny E, Matuszczak S, Wojcieszek P, Urbaś Z, Smolarczyk R. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers (Basel) 2021;13:3924. [PMID: 34439079 DOI: 10.3390/cancers13163924] [Reference Citation Analysis]